<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[JSR Life Sciences, LLC 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=36145></link><description><![CDATA[JSR Life Sciences, LLC 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 18 Apr 2026 14:04:33 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2020/10/12_3554238800_20201021173851_1293919253.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland]]></title><link>https://www.newswire.co.kr/newsRead.php?no=912589</link><description><![CDATA[SUNNYVALE, Calif.--(Business Wire/Korea Newswire)--JSR Life Sciences, LLC today announced that it is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA. The two companies combined will occupy 8,700 square meters in the Stellar 32 campus within Geneva’s ZIPLO (I...]]></description><pubDate>Wed, 21 Oct 2020 17:55:00 +0900</pubDate></item><item><title><![CDATA[JSR 라이프 사이언스, 스위스 제네바의 셀렉시스 및 KBI 바이오파마 제조 설비 확장]]></title><link>https://www.newswire.co.kr/newsRead.php?no=912590</link><description><![CDATA[서니베일, 캘리포니아--(Business Wire/뉴스와이어)--JSR 라이프사이언스(JSR Life Sciences, LLC)가 자회사인 KBI 바이오파마와 셀렉시스 SA의 유럽 내 최첨단 제조 설비를 한 곳에 공동 배치함으로써 유럽에서의 입지를 더욱 확장한다고 20일 발표했다.  KBI 바이오파마와 셀렉시스의 제조 시설은 제네바 ZIPLO(플랑레우아테스 산업공단, Industrial Zone Plan-les-Ouates) 내 스텔라 32 구내에 공동 배치되며 면적은 8,700㎡...]]></description><pubDate>Wed, 21 Oct 2020 17:55:00 +0900</pubDate></item></channel></rss>